Exploring controls on perfluorocarboxylic acid (PFCA) gas–particle partitioning using a model with observational constraints
Environmental Science: Processes & Impacts · 2023
DOI: 10.1039/d2em00261b ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Science: Processes & Impacts, 2023. Verfasst von Ye Tao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, York University, Toronto, Ontario, Canada. youngcj@yorku.ca. Hauptthemen laut MEDLINE: Fluorocarbons. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 93 Literaturangaben. Gefördert von: Environment and Climate Change Canada, Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
The atmospheric fate of perfluorocarboxylic acids (PFCAs) has attracted much attention in recent decades due to the role of the atmosphere in global transport of these persistent chemicals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, York University, Toronto, Ontario, Canada. youngcj@yorku.ca.
Förderung
- Environment and Climate Change Canada
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Tao, Y., VandenBoer, T. C., Ye, R., & Young, C. J. (2023). Exploring controls on perfluorocarboxylic acid (PFCA) gas–particle partitioning using a model with observational constraints. Environmental Science: Processes & Impacts. https://doi.org/10.1039/d2em00261b
Vancouver
Tao Y, VandenBoer TC, Ye R, Young CJ. Exploring controls on perfluorocarboxylic acid (PFCA) gas–particle partitioning using a model with observational constraints. Environmental Science: Processes & Impacts. 2023. doi:10.1039/d2em00261b
BibTeX
@article{Tao2023,
author = {Tao, Ye and VandenBoer, Trevor C and Ye, RenXi and Young, Cora J},
title = {Exploring controls on perfluorocarboxylic acid (PFCA) gas–particle partitioning using a model with observational constraints},
journal = {Environmental Science: Processes & Impacts},
year = {2023},
doi = {10.1039/d2em00261b}
}
EUVIMED